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While it is customary to stress the similarity of X-irradiation and the cyto- 
toxic alkylating agents, we have been impressed by the contrast in the effect 
of X-ray and these drugs on the immune system. The contrast in action of the 
two modalities was observed in the course of earlier studies of two phenomena 
in  CBA mice: immunological tolerance induced with the immunosuppressant 
cyclophosphamide  (1),  and  the  role  of  lethal  irradiation in  unmasking  the 
immune  deficit  of  thymectomized  adult  animals  (2).  Thus,  radiation  could 
not substitute for cyclophosphamide in the drug-tolerance system,  and cyclo- 
phosphamide  was  of  no  use  in  bringing  out  the  thymectomy  defect.  Other 
experiments indicated that  bone marrow  cells, which,  as is well known,  pro- 
tected  animals from  lethal irradiation,  were  of  no  value  against lethal drug 
toxicity. This  dichotomy between  the immune  action of drug  and X-ray ap- 
peared to us to be  of sufficient significance that  additional experiments were 
undertaken to outline the phenomenon.  The present manuscript describes the 
new experiments and discusses the results in terms of the different cellular and 
kinetic mechanisms involved in the action of the two modalities. 
Materials and Methods 
The various techniques employed have been described in detail in earlier publications (1-3). 
Female CBA mice 10-14 wk of age, obtained from the Jackson Laboratory, Bar Harbor, Maine, 
were  used.  Cyclophosphamide  (Cytoxan, Mead  Johnson  Laboratories,  Evansville, Ind.) 
was injected as a freshly made solution containing  5 mg/ml and, unless otherwise stated, the 
drug was given in four divided daffy doses. 
Lethally irradiated mice received 875 R  (280 kv, 1.4 mm Cu, 67 R/rain) and bone marrow 
cells prepared from the femurs of 10 to 20-wk-old mice of the same sex and strain. Subletha]ly 
irradiated animals received 525 R without bone marrow. 
Hemolysin-forming  spleen cells were determined by the method of Jerne (4) as previously 
modified (1). Animals were challenged intravenously with 0.2 ml of 10% sheep cells (5 X  10  s 
cells) 4 days before  sacrifice. An appropriate portion of sieved  spleen was incubated with 
sheep erythrocytes in Gey's solution which was gelled by the addition of agarose. The gelled 
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suspension was incubated at 37°C for 2 hr, 1 ml of 1:10 guinea pig serum was added, and the 
suspension incubated for an additional hour to develop the direct  (19S) plaques. Duplicate 
plates were incubated with rabbit anti-mouse gamma globulin serum (5)  before complement 
addition to determine the indirect (7S) hemolysin-forming  cells. 
TABLE  I 
The Effect of Bone Marrow from Normal and Cyclophosphamide-Treated Animals  on Survival 
after Lethal Irradiation or Cydophosphamide Administration 
Expt. No.  Cyclo-  Bone Marrow  phosphamide*  Radiation  Animals  Survivors$ 
Amount  Source 
(mg/kg)  (R)  (× 109 
300  0  0  14  10 
400  0  0  8  2 
500  0  0  6  0 
600  0  0  8  0 
900  0  0  2  0 
2  400  0  0  7  0 
400  0  5.0  Normal  9  0 
3 a  0  875  4.0  Normal  24  24 
3 b  0  875  2.0  Normal  5  2 
0  875  0.5  Normal  5  3 
0  875  0.05  Normal  5  3 
0  875  0.02  Normal  5  0 
4 a  400  0  0  6  5 
500  0  0  12  0 
0  875  0  6  0 
0  875  0.6  Cytox§  4  0 
4 b  400  0  0  6  0 
0  875  0  6  0 
0  875  1.5  Cytox§  6  0 
* Injected as a single dose. 
$ Alive at 30 days. 
§ Marrow derived from animals (from the same experiment) that had received 400 mg/kg 
of cyclophosphamide  48 hr earlier. 
Adult mice were thymectomized by the previously described method (2), and animals were 
examined at postmortem for gross thymic remnants. Skin grafts were evaluated visually after 
conventional fulLthickness skin grafting (3). Tolerance-inducing injections of sheep erythro- 
cytes consisted of the intravenous injection of 0.8 ml of a 30% suspension of once saline-washed 
fresh sheep celLs immediately before the initial cyclophosphamide injection or as specified in 
the text in relation to irradiation. 
RESULTS 
The Influence  of Bone Marrow from  Normal  and  Cyclophosphamide-Treated 
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Table I presents data from experiments designed to contrast the effectiveness of 
bone marrow in protecting animals after lethal irradiation with the ineffective- 
ness  of  these  cells after  lethal  doses  of  cyclophosphamide. Thus-  CBA  mice 
uniformly die  after  875  R  if  not  given  bone  marrow  (Table  I,  experiments 
4 a  and  b)  while their survival is good if they receive 4  X  106  marrow  cells 
(Table I, experiment 3 a). The data in experiment 3 b  suggest that the marrow 
requirement is satisfied by as little as 5  >(  104 cells. 
TABLE II 
Sheep Cell Response in Normal and Thymectomized Mice after Cyclophosphomide Administration 
and Lethal Irradiation 
Expt.  Thymect-  Cyclophos-  Time 
No.  omy  phamide*  Sheep cells  Radiation~:  plaqued§ 
Plaque-forming spleen cellsl[ 
19S  7S 
(mg/kg)  (R)  (wk) 
--  0  0  0  2~  131,000 
--  200  0  0  2~'6  89,000 
+  200  0  0  2~  110,000 
--  200  6 X  109  0  2~  85 
--  0  0  0  3  84,000  53,000 
--  190  0  0  3  67,000  60,000 
+  190  0  0  3  90,000  81,000 
--  190  6  X  109  0  3  16  0 
3  --  0  0  875  5  19,600 
+  0  0  875  5  150 
* Cyclophosphamide  was given in divided doses for 4 successive days. When a tolerance- 
inducing injection of sheep cells was employed, it was given on the same day as the initial 
cyclophosphamide injection. 
Followed by 5 X  106 bone marrow cells. 
§ From time of drug or irradiation. 
[] Arithmetic mean of the plaque-forming  cells from the individually plagued spleens of 
four to six animals. 
Data in Table I  indicate that single doses of cyclophosphamide of 500 mg/kg 
are  uniformly fatal,  doses  of  300  mg/kg  are usually tolerated,  and  doses  of 
400 mg/kg result in mortality which varies widely from experiment to experi- 
ment.  However,  normal bone  marrow  affords no  protection from  cyclophos- 
phamide mortality even when the drug dose is in the low-lethal range (Table 
I, experiment 2). 
Since  bone  marrow  fails to  protect  animals  from  fatal  cyclophosphamide 
toxicity,  one  may  inquire  whether  these  animals  are  dying  with  adequate 
numbers of hematopoietic stem cells in their marrow. To answer this question, 
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used  as  marrow  donors  for  lethally  irradiated  recipients.  Other  (cyclophos- 
phamide  control)  animals  received  the  drug  and  were  observed for drug  tox- 
icity. The two experiments differed in that in one (Table I, experiment 4 a) five 
of six  drug  control  animals  survived  30  days  while  in  the  other  experiment 
(Table I, experiment 4 b) they all died. However, in neither instance was bone 
marrow  from  cyclophosphamide-treated  donors  able  to  salvage  animals  after 
lethal irradiation. 
Cyclophosphamide  Administration  in  Normal  and  Thymectomized  Mice.- 
The  experiments  illustrated  in Tables  II and  III explore the  ability of cyclo- 
phosphamide  to  expose  the  immunological  deficit  of  thymectomized  adult 
TABLE  III 
Skin Graft Survival in Normal and  Thymectomized CBA  Mice after Cyclophosphamide and 
Lethal Irradiation 
Group  Thy-  Cyclo-  Radia-  Bone  Skin graft survi,Jal~ 
No.  meet-  phos-  tion  marrow 
omy  phomide*  C57BL  AKR 
(mg/kg)  (R)  (X 106) 
1  --  0  0  0  13  (13,  13, 13, 13)  13 (13, 13, 13, 15) 
2  --  150  0  0  13 (13, 13, 13)  13 (13, 13, 13, 13) 
3  --  250  0  0  13 (13, 13, 13)  13 (13, 13, 17) 
4  +  150  0  0  13 (13, 13, 13)  13 (13, 13, 15) 
5  +  250  0  0  13 (13, 13, 13)  15 (15, 15, 15) 
6  +  0  0  0  13 (13, 13, 13, 13)  13 (13, 13, 13, 13) 
7  --  0  850  5  14 (13, 15)  17 (17, 17) 
8  +  0  850  5  61 (19, 61, 61, 61, 91)  200+  (61,  200+, 
200+, 200+) 
200+, 
* Cyclophosphamide  injected  in divided dosage on day of grafting and 3 successive days. 
Median survival.  Survival of individual  grafts in parentheses. 
mice. The data in Table II indicate  that the  drug was ineffective in depleting 
hemolysin-forming spleen cells, while from Table III it is clear that the chemi- 
cal  does  not  prolong  the  survival  of  either  H-2-compatible  (AKR)  or H-2- 
incompatible  (C57BL)  skin  homografts  in  thymectomized  animals.  In  con- 
trast,  thymectomized  mice  after  lethal  irradiation  show  a  marked  deficiency 
of  hemolysin-forming  spleen  cells  (Table  II)  and  prolongation  of  skin  graft 
survival (Table III). 
The Inability of Lethal and Sublethal Irradiation to Induce Tolerance to Sheep 
Erythrocytes.--Table  IV  depicts  two  experiments  in  which  an  attempt  was 
made  to  induce  tolerance  to  sheep  cells  by lethal  and  sublethal  irradiation. 
The  dose  of sheep  erythrocytes  (6)<  109) employed  here  regularly  produces 
complete  immunological  tolerance  when given with  cyclophosphamide  (Table 
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that  have  received sheep  cells show  only  immunization.  Such  immunization 
follows both lethal irradiation with bone marrow and sublethal irradiation, and 
occurs regardless of whether  the  sheep  erythrocytes are given together with, 
precede, or follow, the irradiation (Table IV, experiment 2). 
TABLE IV 
Failure to Induce Tolerance to Sheep  Cells with Lethal and Sublethal Irradiation 
Experi-  Sheep Cells  Radia-  Bone  marrow  Time§  Plaque-forming  cells 
ment  Amount  Day*  tion  19S  7S 
(e)  (wk) 
0  875  5 X  106  5  22,000  15,000 
6 X  109  0  875  5 X  106  5  22,000  >40,000 
0  525  0  5  1,100  650 
6 X  10  °  0  525  0  5  9,800  >30,000 
0  875  5 X  106  10  30,100  20,000 
6 X  109  0  875  5 X  106  10  5,100  >100,000 
0  525  0  10  12,200  5,300 
6 X  109  0  525  0  10  5,100  100,000 
0  875  5 )< 106  5  6,100  6,900 
6 X  109  -2  875  5 X  106  5  77,000  38,000 
6 X  10  o  -1  875  5 X  106  5  98,000  123,000 
6 X  109  0  875  5 X  106  5  83,000  89,000 
6 X  109  1  875  5 X  106  5  88,000  128,000 
6 X  109  +2  875  5 X  10  a  5  107,000  115,000 
* Day 0 is the day of irradiation. There were five animals in each group in experiment 1 
and four animals in each group in experiment 2. 
§ Weeks after irradiation that spleens were plaqued. Animals that received the tolerance- 
inducing injection of sheep cell also received twice weekly intraperitoneal injections of 5 X  10  s 
cells. 
DISCUSSION 
Our  observations on the effects of lethal irradiation and  cyclophosphamide 
injection on immunological reactivity of CBA mice are summarized in Table V. 
The  data  that have  been presented  indicate that  lethal irradiation  (but not 
cyclophosphamide)  leads  to  profound  immune  impairment  in  the  thymec- 
tomized animal whereas cyclophosphamide (but not radiation)  easily induces 
immunological tolerance. Furthermore, bone marrow cells protect against the 
lethal effects of irradiation (875 R) but not against the drug, and earlier studies 
have  established  that  lethal  irradiation  (2)  depletes  the  spleen  more  pro- 
foundly than  tolerated doses of cyclophosphamide (6). While no one  of these 
observations taken  by  itself is  sufficient,  taken  together  they  represent  con- 
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of  this  drug  and  radiation.  (Both  cyclophosphamide  and  X-ray  produce  a 
temporary nonspecific depression  of immunological reactivity [7]). 
A  critical  analysis  of  the  mode of  action  of X-irradiation  and  cyclophos- 
phamide has been made by Bruce,  Meeker,  and Valeriote  (8). Their essential 
observation  is  that  nondividing  normal  hematopoietic  stem  cells  from bone 
marrow  display  the  same  radiation  sensitivity  as  do  rapidly  dividing  lym- 
phoma cells,  while the lyinphoma cells are much more sensitive to  cyclophos- 
phamide.  From this observation they conclude that cyclophosphamide action 
depends markedly on the rate of cell proliferation while  irradiation does not. 
(In  addition,  the  shape  of  the  dose:survival  curv';  h':,ds  these  authors  to 
TABLE V 
Comparison of Effects of Lethal Irradiation arzd Cyclsphosphamide Injection in CBA Mice 
Lethal irradiation  Cyclophospham[de 
Protection by bone marrow  + 
Protection  of immune impair-  + 
ment in thymectomized ani- 
mal 
Induction of immune tolerance 
Nonspecific  immune impair-  +  (7) 
ment 
Reduction in number of spleen  6/221  (2) 
cells* 
Dependence of lethal effect on 
rate of cell proliferation (8) 
+ 
+  (7) 
4o/18o  (~ 
+ 
* Expres~,ed as millions of spIeen  cell at maximum drug or radiation effect over initial value. 
conclude that both irradiation  and cyclophosphamide kill cells in all portions 
of the gen ~ration cycle [8]). 
The  conclusions  of Bruce  et al.  are useful  in  analyzing the  effects of radi- 
ation  :,,~i  :vc!ophosphamide on  immune parameters.  The  tolerance-inducing 
."tp:city of the drug can be related to destruction of a rapidly proliferating cell 
': 'resumably replicating in response to antigenic stimulation) which is destroyed 
oy  the  same  mechanism  that  destroys  the  rapidly  dividing  lymphoma cell. 
The radiation-sensitivity  and  cyclophosphamide-insensitivity of the  immune 
responses  of  the  thymectomized  animal  implies  that  the  cell  depleted  here, 
like  the  marrow stem cell,  is  not  actively" proliferating.  Since  bone  marrow 
does not  relieve the  immune defect of the  thymectomized irradiated  animal, 
it seems clear that the cell depleted by irradiation is not the marrow stem cell 
itself,  but  rather  a  lymphoid  cell  (perhaps  derived  from it  by thymus  pro- 
cessing) that shares a slow mitotic rate. 
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that  received  cyclophosphamide  (Table  I,  experiment  4)  is  not  conclusive 
evidence  that  drug-treated  animals  lack  sufficient hematopoietic stem  cells 
to survive. Thus,  in earlier work (3)  we found that marrow from mice that 
received 525  R  (a  sublethal  dose)  was  unable  to  sustain  lethally irradiated 
animals, and even the modest dose of 262 R  impaired the resuscitative quality 
of marrow. Clearly, the answer is to be found in a quantitative consideration 
of  the  number  of hematopoietic stem  cells needed for  survival.  Data  from 
Bruce et al.  (8)  indicates that 400 mg/kg of cyclophosphamide (8 mg/mouse) 
reduces the number of  marrow stem cells to approximately 1%  that  of un- 
treated animals. A survival figure very close to 1% is also obtained from the 
same reference for stem cells subjected to 525 R, a dose which is well tolerated 
by the CBA mouse. (The LDs0 for female CBA mice is 689 4- 8 R  (9), a radi- 
ation dose which reduces stem cell survival to 0.1% [8]). Presumably, the 1% 
survival reduces the viable stem cells in the transplanted marrow below the 
5  )<  104 (approximately) that is needed for survival. In any event, it seems 
clear that  the cyclophosphamide-treated mouse dies  of causes in addition to 
lack  of hematopoietic stem  ceils,  and  it  seems likely  (from consideration of 
the radiation data above) that such animals have sufficient marrow stem cells 
to survive. 
We  recognize that  the  reasoning  of the  two previous paragraphs,  though 
plausible,  is  based  on  indirect  evidence,  and  the  conclusion derived cannot 
be proposed with  certainty. It is  also possible  that  additional permutations 
in the fractionation and dose of drug and radiation might lead to somewhat 
different results  (10).  Nevertheless, it seems  to us quite clear that  the drug 
cyclophosphamide  and  X-irradiation  suppress  immunity  by  quite  separate 
and distinct mechanisms. Other investigators have reached a similar conclusion 
from different data (11,  12). 
SUMMARY 
The  immunosuppressant  cyclophosphamide  easily  induces  specific  im- 
munological tolerance in CBA mice, but is unable to produce an immunological 
defect in  adult  thymectomized animals.  In contrast,  lethM  (and  sublethal) 
irradiation does not induce tolerance but readily brings out the deficit of thy- 
mectomy. Furthermore,  bone marrow cells which protect lethally irradiated 
animals do not prevent drug deaths. 
This sharp dichotomy indicates that  the drug  and  radiation influence the 
lymphoid system by different mechanisms.  It seems likely from the work of 
others  that  cyclophosphamide  action  is  markedly  dependent  on  rapid  cell 
proliferation, while radiation is not. From this it follows that the cell which 
must be depleted to expose the immune defect of the thymectomized animal 
is a nonproliferating lymphoid element with the slow mitotic rate of the marrow 
stem cell. 884  EFFECTS  OF  CYCLOPI{OSPHAMIDE AND  RADIATION 
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